It also reduces tumour cell invasiveness by downregulating several invasion-related factors, including TGF-β1, urokinase plasminogen activator (uPA), and matrix metalloproteinases (MMPs)-2 and -9, which are produced by tumour cells (Zhang et al, 2000). Here, TGFB1 is linked to neoplasm.